COLISTYN

Active Principle: Colistin Sodium Metasulfate.
Therapeutic Effect: Antibiotic for chronic infections – Cystic Fibrosis.
Composition: Powder for injections: Each 2 ml solvent ampoule contains Colistin (as Sodium methanesulfonate) – 100 mg vial. Solution for nebulization: Each vial of extemporaneous preparation Colistin (as sodium methanesulfonate) 100 mg. Injection: Each 2 ml vial contains Colistin (as colistimethate sodium) 150 mg. Injection/Inhalation Solution 80 mg: Each vial contains Colistimethate sodium 80 mg (1 MIU). Injection/Inhalation Solution 160 mg: Each vial contains Colistimethate Sodium 160 mg (2 MIU). 80 mg inhalation solution: Each extemporaneous preparation bottle contains Sodium Colistimethate 80 mg (1 MIU). 160 mg inhalation solution: Each extemporaneous preparation vial contains Sodium Colistimethate 160 mg (2 MIU).
How Supplied: Powder for injections: Packages containing 1 and 4 single-dose vials plus vials with 2 ml of solvent. Solution for nebulization: Containers containing 1 vials for extemporaneous preparation plus 4 ml of purified water. Injectable: Packages containing 1 and 6 vials. Injection/Inhalation solution: Packages containing 1 and 4 single-dose vials plus 2 ml vials of solvent, for both concentrations. Inhalation solution: Containers for 1 and 4 bottles of extemporaneous preparation plus 4 ml of purified water, for both concentrations.